Title: Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
Journal: ACS medicinal chemistry letters 20111208
Title: Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.
Journal: ACS medicinal chemistry letters 20110609
Title: Xue CB, et al. Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett. 2011 Mar 31;2(6):450-4.
Title: McMillin M, et al. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation. 2014 Jul 10;11:121.
